Equity · United States · Large cap · Risk paritySFDR art. 6
Index tracked: S&P 500 Equal Weight Net Total Return
TER
0.20%+ trans. 0.08%
Fund size
1 bn EUR
Tracking difference
—not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Synthetic (swap)
Income
Accumulating
Launch 14 Jan 2025 · costs from the KID as of 14 Aug 2026 · 244 securities held · 9 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 2 Sept 2026
Redemption and Dealing of Shares:
The Fund's shares are listed on one or more Stock Exchange(s). Investors can buy or sell shares daily through an intermediary directly or on Stock Exchange(s) on which the shares are traded. In exceptional circumstances investors will be permitted to redeem their shares directly from the Umbrella Fund in accordance with the redemption procedures set out in the prospectus, subject to any applicable laws and relevant charges. Investment objective: The investment objective of the Fund is to provide exposure to the…
Performance since series start (in euro) — base 100
14 Jan 2025 → 13 Aug 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
High 115 (13 Aug 2026) · low 82 (8 Apr 2025) · last 115. Past performance is not indicative of future results.
RebalixRSPS · IE0000TZZ2B2 · sheet of 4 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years
Not honestly computable: index series not published by the issuer
Holdings
Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 31 Aug 2026 · 244 securities · top-10 weight = 26.5%
The live sheet, always up to date rebalix.com/en/etf/IE0000TZZ2B2 Series, distributions, holdings and documents refresh daily.
Sheet produced on 4 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.